Approvals/TGA/Flublok Quadrivalent quadrivalent recombinant influenza vaccine, solution for injection, syringe

Approved

STANDARD

Flublok Quadrivalent quadrivalent recombinant influenza vaccine, solution for injection, syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c8cdbfe2ae9bc8d1
Product Name: Flublok Quadrivalent quadrivalent recombinant influenza vaccine, solution for injection, syringe
Artg Id: 325683
Artg Name: Flublok Quadrivalent quadrivalent recombinant influenza vaccine, solution for injection, syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2021-05-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f9352fb85664234f1d2a0cfdc09036b0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

c8cdbfe2ae9bc8d1

Type

Standard